Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.
Acinetobacter
Pseudomonas
Enterobacteriaceae
carbapenem resistance
prevention and control
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
received:
27
03
2018
accepted:
26
09
2018
pubmed:
27
11
2018
medline:
9
4
2020
entrez:
27
11
2018
Statut:
ppublish
Résumé
Carbapenem-resistant Enterobacteriaceae (CRE), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPsA) are a serious cause of healthcare-associated infections, although the evidence for their control remains uncertain. We conducted a systematic review and reanalysis to assess infection prevention and control (IPC) interventions on CRE-CRAB-CRPsA in inpatient healthcare facilities to inform World Health Organization guidelines. Six major databases and conference abstracts were searched. Before-and-after studies were reanalyzed as interrupted time series if possible. Effective practice and organization of care (EPOC) quality criteria were used. Seventy-six studies were identified, of which 17 (22%) were EPOC-compatible and interrupted time series analyses, assessing CRE (n = 11; 65%), CRAB (n = 5; 29%) and CRPsA (n = 3; 18%). IPC measures were often implemented using a multimodal approach (CRE: 10/11; CRAB: 4/5; CRPsA: 3/3). Among all CRE-CRAB-CRPsA EPOC studies, the most frequent intervention components included contact precautions (90%), active surveillance cultures (80%), monitoring, audit and feedback of measures (80%), patient isolation or cohorting (70%), hand hygiene (50%), and environmental cleaning (40%); nearly all studies with these interventions reported a significant reduction in slope and/or level. The quality of EPOC studies was very low to low.
Identifiants
pubmed: 30475989
pii: 5201688
doi: 10.1093/cid/ciy752
pmc: PMC6389314
doi:
Substances chimiques
Anti-Bacterial Agents
0
Carbapenems
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
873-884Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
J Clin Epidemiol. 2016 Feb;70:191-9
pubmed: 26388040
Clin Infect Dis. 2013 Nov;57(9):1246-52
pubmed: 23946222
Infect Control Hosp Epidemiol. 2017 May;38(5):580-594
pubmed: 28294079
Am J Infect Control. 2011 Oct;39(8):671-677
pubmed: 21864942
J Intern Med. 2015 May;277(5):501-12
pubmed: 25556628
Clin Microbiol Infect. 2015 Dec;21(12):1057-66
pubmed: 26435462
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1315-1322
pubmed: 27609341
Lancet Infect Dis. 2007 Apr;7(4):282-8
pubmed: 17376385
Infect Control Hosp Epidemiol. 2009 Jul;30(7):611-22
pubmed: 19508124
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038269
Epidemiol Infect. 2012 Dec;140(12):2131-41
pubmed: 22335933
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
Clin Microbiol Infect. 2017 Mar;23(3):188-196
pubmed: 27746394
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Expert Rev Anti Infect Ther. 2016 Aug;14(8):705-17
pubmed: 27348447
Am J Infect Control. 2014 Dec;42(12):1270-3
pubmed: 25465255
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55
pubmed: 24329732
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Clin Microbiol Infect. 2014 May;20(5):416-23
pubmed: 24131374
Antimicrob Resist Infect Control. 2017 Nov 15;6:113
pubmed: 29163939
Clinics (Sao Paulo). 2013;68(8):1128-33
pubmed: 24037009
Clin Microbiol Infect. 2010 Feb;16(2):102-11
pubmed: 20085604
Am J Infect Control. 2015 Nov;43(11):1171-7
pubmed: 26297525
Euro Surveill. 2014 Oct 30;19(43):
pubmed: 25375901
Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7
pubmed: 24915208
J Hosp Infect. 2011 Sep;79(1):49-53
pubmed: 21722990
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
pubmed: 18068815
Am J Infect Control. 2014 May;42(5):466-71
pubmed: 24773784
Infect Control Hosp Epidemiol. 2010 Jun;31(6):620-6
pubmed: 20370465
Lancet. 2005 Oct 8;366(9493):1246-7
pubmed: 16214584
Am J Infect Control. 2014 Sep;42(9):976-9
pubmed: 25179329
BMC Infect Dis. 2011 Oct 13;11:272
pubmed: 21995287
Clin Microbiol Infect. 2014 Sep;20(9):854-61
pubmed: 24980472
Clin Infect Dis. 2011 Apr 1;52(7):848-55
pubmed: 21317398
Infect Control Hosp Epidemiol. 2011 Dec;32(12):1158-65
pubmed: 22080653
Clin Infect Dis. 2015 Apr 15;60(8):1153-61
pubmed: 25537877
Emerg Microbes Infect. 2016 Mar 23;5:e27
pubmed: 27004762
Clin Microbiol Infect. 2015 Mar;21(3):242-7
pubmed: 25658534
Emerg Infect Dis. 2014 Jul;20(7):1170-5
pubmed: 24959688
Am J Infect Control. 2016 Nov 1;44(11):1374-1380
pubmed: 27156198
Int J Surg. 2010;8(5):336-41
pubmed: 20171303